Evidence map›Paper›PMID 39063742›Full record

ArticleMaterials (Basel, Switzerland)2024

The Potential of Wire Explosion in Nanoparticle Production in Terms of Reproducibility.

László Égerházi, Tamás Szörényi

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

László ÉgerháziDepartment of Medical Physics and Informatics, Albert Szent-Györgyi Medical School, University of Szeged, H-6720 Szeged, Hungary.ORCID 0000-0003-4411-7465
Tamás SzörényiDepartment of Optics and Quantum Electronics, University of Szeged, H-6720 Szeged, Hungary.ORCID 0000-0002-8888-4167

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aquasols produced by exploding copper wires represent complex systems in which identifying individual colloidal components poses challenges due to broad and multimodal size distributions and varying shares among oxidation states. To evaluate the reproducibility of copper wire explosion, the size distribution of metallic and oxidized colloidal components within the 10-300 nm diameter range was assessed. Classification of each individual particle into bins according to size and chemical composition was accomplished by reconstructing the recorded optical extinction spectra of three sols produced under identical conditions as the weighted sum of the extinction spectra of individual copper and copper-oxide particles, computed using Mie theory. Our spectrophotometry-based component analysis revealed differences in particle number concentrations of the mainly oxidized nanoparticles, corresponding to deviations observed in the ultraviolet portion of the extinction spectra. Notable uniformity was observed, however, in the number of metallic fine particles, consistent with agreement in spectral features in the visible range. Regarding mass concentration, practically no differences were observed among the three samples, with nano-to-fine ratios of copper particles agreeing within 0.45%. Despite the complex processes during explosion leading to limited reproducibility in the ratio of different copper oxidation states, very good reproducibility (54.2 ± 0.7%) was found when comparing the total copper content of the samples to the mass of the exploded copper wire.

Indexed as

copper wire explosionnanoparticlesoptical extinction spectroscopyoxidation statesparticle size distributionreproducibility

Identifiers

PMID39063742
PMCPMC11278331

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.